Recent Press Releases

KaloBios Provides Update on KB001-A Partnership and Clinical Status

SOUTH SAN FRANCISCO, Calif. -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of the KB001-A development program, including an update on its KB001-A...

IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p

HORSHAM, Pa., July 28, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for IMBRUVICA® (ibrutinib) capsules for the...

Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital

DANBURY, CT, Jul 28, 2014 (Marketwired via COMTEX) -- Biodel Inc. BIOD -3.65% today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC...

Retrophin Proposes Acquisition of Clinuvel Pharmaceuticals

July 27, 2014 11:47 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that on July 17, 2014 it submitted a proposal to the Board of Directors of...

AstraZeneca and Roche announce partnership to develop companion diagnostic test for AZD9291

AstraZeneca today announced it has entered into collaboration with Roche to develop a plasma-based companion diagnostic test to support AZD9291, AstraZeneca's investigational compound in clinical...

Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing

Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing Proceeds to Support New European Operations and Clinical Development, Regulatory Review and Anticipated Global Launch of...

Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines

Jul 28, 2014 (GLOBE NEWSWIRE via COMTEX) -- Company Announcement No. 11/2014 Zealand eligible to receive up to EUR 295 million in potential milestone payments for the first commercialized product...

AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™ REDWOOD CITY, Calif., July 25, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (...

Global Computational Biology Market By Application (Cellular & Biological Simulation, Pharmacogenomics, Drug Discovery), By Services (In-house, Contract), By End User (Academics, Industry, Commercial) Expected To Reach USD 4,285.1 Million By 2020

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the...

Amgen Announces 2014 Third Quarter Dividend

THOUSAND OAKS, Calif., July 25, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directo

European CHMP Adopts Positive Opinion for Gilead's Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma

FOSTER CITY, Calif.--Jul. 25, 2014-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European...

Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology

NEW YORK -- Keryx Biopharmaceuticals, Inc. (KERX) (the "Company") announced the publication of results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric...

Ultragenyx Pharmaceuticals (RARE) Appoints Sunil Agarwal, M.D. As Chief Medical Officer And Senior Vice President

NOVATO, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare...

Innocoll AG Announces Pricing of Initial Public Offering

ATHLONE, Ireland, July 25, 2014 -- Innocoll AG (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...

AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder As Chief Financial Officer

SKOKIE, Ill., July 23, 2014 /PRNewswire/ -- AuraSense Therapeutics, the pioneer in developing spherical nucleic acid (SNA) constructs as gene regulatory and immunotherapeutic agents, announced today...

Zenith Epigenetics Appoints Julie Cherrington As President And CEO

CALGARY, July 23, 2014 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that it has appointed Julie Cherrington PhD to act as the President and...

ConMed Corporation (CNMD) Announces Leadership Transition

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford Finance Joseph Corasanti Steps Down as CEO Founder Gene Corasanti Retires Independent Board Member Curt Hartman...

BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors - 7/22

RALEIGH, N.C., July 22, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr....